High cell surface expression of CD4 allows distinction of CD4+CD25+ antigen-specific effector T cells from CD4+CD25+ regulatory T cells in murine experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 192, Issue 1-2, 2007, Pages 57-67

  Li, Jinzhu ^a   Ridgway, William ^c   Fathman, C Garrison ^b   Tse, Harley Y ^a   Shaw, Michael K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CD25; CD4; Cellular proliferation; Experimental autoimmune encephalomyelitis; FACS; T cells; Treg

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MEMBRANE ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; INTERFERON TYPE II; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7; MICE; MICE, INBRED C57BL; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 36749005547     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.09.004     Document Type: Article

References (53)

1. Amor S., Baker D., Groome N., and Turk J.L. Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice. J. Immunol. 150 12 (1993) 5666-5672
2. Amor S., Groome N., Linington C., Morris M.M., Dornmair K., Gardinier M.V., Matthieu J.M., and Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153 10 (1994) 4349-4356
3. Ando D.G., Clayton J., Kono D., Urban J.L., and Sercarz E.E. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124 1 (1989) 132-143
4. Asano M., Toda M., Sakaguchi N., and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184 2 (1996) 387-396
5. Bernard C.C. Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J. Immunogenet. 3 4 (1976) 263-274
6. Chang X., Gao J.X., Jiang Q., Wen J., Seifers N., Su L., Godfrey V.L., Zuo T., Zheng P., and Liu Y. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J. Exp. Med. 202 8 (2005) 1141-1151
7. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., Zurawski S., Wiekowski M., Lira S.A., Gorman D., Kastelein R.A., and Sedgwick J.D. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 6924 (2003) 744-748
8. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 4 (2003) 330-336
9. Ford D., and Burger D. Precursor frequency of antigen-specific T cells: effects of sensitization in vivo and in vitro. Cell. Immunol. 79 2 (1983) 334-344
10. Gebel H.M., Scott J.R., Parvin C.A., and Rodey G.E. In vitro immunization to KLH. II. Limiting dilution analysis of antigen-reactive cells in primary and secondary culture. J. Immunol. 130 1 (1983) 29-32
11. Green E.A., Choi Y., and Flavell R.A. Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16 2 (2002) 183-191
12. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., and Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 6652 (1997) 737-742
13. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., and Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 11 (2005) 1123-1132
14. Huehn J., Siegmund K., Lehmann J.C., Siewert C., Haubold U., Feuerer M., Debes G.F., Lauber J., Frey O., Przybylski G.K., Niesner U., de la R.M., Schmidt C.A., Brauer R., Buer J., Scheffold A., and Hamann A. Developmental stage, phenotype, and migration distinguish naive-and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199 3 (2004) 303-313
15. Johns T.G., Kerlero de R.N., Menon K.K., Abo S., Gonzales M.F., and Bernard C.C. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154 10 (1995) 5536-5541
16. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4 4 (2003) 337-342
17. Kohm A.P., Carpentier P.A., Anger H.A., and Miller S.D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169 9 (2002) 4712-4716
18. Kojima M., Cease K.B., Buckenmeyer G.K., and Berzofsky J.A. Limiting dilution comparison of the repertoires of high and low responder MHC-restricted T cells. J. Exp. Med. 167 3 (1988) 1100-1113
19. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., and Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177 1 (2006) 566-573
20. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., Backstrom B.T., Sobel R.A., Wucherpfennig K.W., Strom T.B., Oukka M., and Kuchroo V.K. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13 4 (2007) 423-431
21. Kuniyasu Y., Takahashi T., Itoh M., Shimizu J., Toda G., and Sakaguchi S. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol. 12 8 (2000) 1145-1155
22. Lahl K., Loddenkemper C., Drouin C., Freyer J., Arnason J., Eberl G., Hamann A., Wagner H., Huehn J., and Sparwasser T. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204 1 (2007) 57-63
23. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 2 (2005) 233-240
24. Lejon K., and Fathman C.G. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker. J. Immunol. 163 10 (1999) 5708-5714
25. Lyons J.A., Ramsbottom M.J., Trotter J.L., and Cross A.H. Identification of the encephalitogenic epitopes of CNS proteolipid protein in BALB/c mice. J. Autoimmun. 19 4 (2002) 195-201
26. McHugh R.S., Whitters M.J., Piccirillo C.A., Young D.A., Shevach E.M., Collins M., and Byrne M.C. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16 2 (2002) 311-323
27. Mendel I., Natarajan K., Ben Nun A., and Shevach E.M. A novel protective model against experimental allergic encephalomyelitis in mice expressing a transgenic TCR-specific for myelin oligodendrocyte glycoprotein. J. Neuroimmunol. 149 1-2 (2004) 10-21
28. Mokhtarian F., McFarlin D.E., and Raine C.S. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309 5966 (1984) 356-358
29. Mokhtarian F., McFarlin D.E., and Raine C.S. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309 5966 (1984) 356-358
30. Pace L., Pioli C., and Doria G. IL-4 modulation of CD4+CD25+ T regulatory cell-mediated suppression. J. Immunol. 174 12 (2005) 7645-7653
31. Pagliarulo V., George B., Beil S.J., Groshen S., Laird P.W., Cai J., Willey J., Cote R.J., and Datar R.H. Sensitivity and reproducibility of standardized-competitive RT-PCR for transcript quantification and its comparison with real time RT-PCR. Mol. Cancer 3 (2004) 5
32. Pettinelli C.B., and McFarlin D.E. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1 + 2-T lymphocytes. J. Immunol. 127 4 (1981) 1420-1423
33. Powell M.B., Mitchell D., Lederman J., Buckmeier J., Zamvil S.S., Graham M., Ruddle N.H., and Steinman L. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2 6 (1990) 539-544
34. Reddy J., Illes Z., Zhang X., Encinas J., Pyrdol J., Nicholson L., Sobel R.A., Wucherpfennig K.W., and Kuchroo V.K. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 101 43 (2004) 15434-15439
35. Ridgway W., Fasso M., and Fathman C.G. Following antigen challenge, T cells up-regulate cell surface expression of CD4 in vitro and in vivo. J. Immunol. 161 2 (1998) 714-720
36. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 3 (1995) 1151-1164
37. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., Shimizu J., Takahashi T., and Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212 (2006) 8-27
38. Sakai K., Zamvil S.S., Mitchell D.J., Lim M., Rothbard J.B., and Steinman L. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J. Neuroimmunol. 19 1-2 (1988) 21-32
39. Segal B.M., Dwyer B.K., and Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187 4 (1998) 537-546
40. Shaw M.K., Kim C., Ho K.L., Lisak R.P., and Tse H.Y. A combination of adoptive transfer and antigenic challenge induces consistent murine experimental autoimmune encephalomyelitis in C57BL/6 mice and other reputed resistant strains. J. Neuroimmunol. 39 1-2 (1992) 139-149
41. Shaw M.K., Kim C., Hao H.W., Chen F., and Tse H.Y. Induction of myelin basic protein-specific experimental autoimmune encephalomyelitis in C57BL/6 mice: mapping of T cell epitopes and T cell receptor V beta gene segment usage. J. Neurosci. Res. 45 6 (1996) 690-699
42. Shaw M.K., Li J., Ho P., Hoa H., Lisak R.P., and Tse H.Y. Induction of myelin basic protein-specific adoptive experimental autoimmune encephalomyelitis in C57BL/6 mice: longevity of donor T cells and lack of disease relapses. In: Broglio P. (Ed). Neuroimmunology Research Focus (2007), Nova Science Publishers, Inc.
43. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., and Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3 2 (2002) 135-142
44. Standifer N.E., Kraig E., and Infante A.J. A hierarchy of T cell receptor motifs determines responsiveness to the immunodominant epitope in experimental autoimmune myasthenia gravis. J. Neuroimmunol. 145 1-2 (2003) 68-76
45. Sutton C., Brereton C., Keogh B., Mills K.H., and Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203 7 (2006) 1685-1691
46. Swanborg R.H. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol. Immunopathol. 77 1 (1995) 4-13
47. Tompkins S.M., Padilla J., Dal Canto M.C., Ting J.P., Van K.L., and Miller S.D. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 168 8 (2002) 4173-4183
48. Traugott U., Raine C.S., and McFarlin D.E. Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell. Immunol. 91 1 (1985) 240-254
49. Traugott U., McFarlin D.E., and Raine C.S. Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Cell. Immunol. 99 2 (1986) 395-410
50. Trotter J.L., Clark H.B., Collins K.G., Wegeschiede C.L., and Scarpellini J.D. Myelin proteolipid protein induces demyelinating disease in mice. J. Neurol. Sci. 79 1-2 (1987) 173-188
51. Tuohy V.K., Lu Z., Sobel R.A., Laursen R.A., and Lees M.B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142 5 (1989) 1523-1527
52. Zamvil S., Nelson P., Trotter J., Mitchell D., Knobler R., Fritz R., and Steinman L. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317 6035 (1985) 355-358
53. Zamvil S.S., Mitchell D.J., Moore A.C., Kitamura K., Steinman L., and Rothbard J.B. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324 6094 (1986) 258-260